&w=3840&q=100)
Bharat Forge acquires AAM India Manufacturing for ₹746.46 crore
Pune-based Bharat Forge acquired AAM India Manufacturing at an equity value of ₹746.46 crore. The acquired company has ₹189.48 crore cash on its books, which will be used to support future growth of the company. ''The final equity value is subject to net working capital adjustments as of June 30, 2025'', the company said.
AAM India Manufacturing is an axle manufacturer of light, medium and heavy commercial vehicles in India. The company operates major manufacturing facilities in Pune and Chennai, as well as an engineering and development center in Pune.
The Competition Commission of India (CCI) had approved the proposed acquisition on April 22, 2024.
Bharat Forge is an engineering and manufacturing company, specialising in forged and machined components for the automotive, industrial, and defense sectors.
Internal restructuring
In June, Bharat Forge Limited had conducted internal restructuring by transferring its defence business to its wholly owned subsidiary, Kalyani Strategic Systems Limited (KSSL). As part of the exercise, Bharat Forge signed an agreement to transfer BFL's certain defence assets to KSSL. This transfer is being executed at fair market value as determined by an independent valuer. In return, KSSL will issue Optionally Convertible Redeemable Preference Shares (OCRPs) to Bharat Forge as consideration for the transaction.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
42 minutes ago
- Mint
Sebi's Jane Street interim order made India's stock market sit up for good reason
The stock market has been forced to sit up by an interim order passed by the Securities and Exchange Board of India (Sebi) against New York-based securities firm Jane Street. The order has fired the imagination of sundry arbitrageurs and mollified traders who were alarmed by rising levels of risk in India's capital markets. Sebi has been alerting the public about rising risk in the equity futures and options (F&O) segment and taking prudential steps. Last week, after a long probe, it barred Jane Street's four trading arms from transacting in the Indian securities markets till it completes its 'detailed' investigation. The capital market regulator has also sought to disgorge ₹4,844 crore from the securities firm. Sebi's order alleges that Jane Street's associate arms indulged in market manipulation—specifically of Bank Nifty index derivatives and this index's constituent shares in the cash segment. Also Read: Mint Explainer: How Sebi sniffed out Jane Street's market manipulations Jane Street allegedly ignored a February advisory from the first-level regulator, National Stock Exchange (NSE), leading Sebi to comment in its order that it is not 'a good faith actor that can be, or deserves to be, trusted." The whole affair not only raises many questions, but points to some macro issues as well. The first question arises from the way in which Sebi chanced upon Jane Street's alleged misconduct. Media reports in April 2024 detailed how Jane Street had sued two former employees in a Manhattan court for allegedly using the firm's 'proprietary trading strategy' in their new firm. The lawyers of the accused revealed in court that the strategy was being deployed in India. This reportage alerted Sebi, which then began its initial probe into Jane Street's trades in the Indian market's cash and derivative segments, which included directing NSE to keep a close watch on the firm's trading patterns. While Sebi must be lauded for its alacrity and the time it took to marshal and establish the facts of this case—from April 2024 to July 2025—a question could be raised about its source of information. To be fair, Sebi can always respond to alerts of any viable origin. However, Jane Street's trading strategy was at work for more than a year before April 2024, having flown below Sebi's vigilance and surveillance radars. Thereby hangs a lesson. Also Read: Street theatre: Sebi pins down Jane Street for manipulation Another issue that should be debated is whether Jane Street's trading strategy was illegal—or 'manipulation" as per the Indian regulator's interim order. Many F&O traders have adopted similar strategies in the past and escaped scrutiny. Jane Street's large volumes in a shallow market made the difference; but then, can the securities firm be blamed for structural deficiencies in our derivatives market? What's more important, though, is the fact that Jane Street allegedly profited on the back of uninformed derivatives trading by retail investors. Sebi's September 2024 report had stated that over 90% of retail investors in the F&O market had incurred losses between 2021-22 and 2023-24. This then calls for a larger investigation into whether retail investors were led up the garden path and if the entities that operated as pied pipers were acting on behalf of Jane Street. Also Read: F&O action: Can new Sebi rules tame wild bulls of the derivatives market? Sebi's F&O risk mitigation strategy, which has included raising the bar for futures and options trading, may need some course correction. The regulator must ensure that the bar is raised sufficiently to deter non-institutional investors from treating the derivatives segment of the market like a casino without a cover charge.
Economic Times
43 minutes ago
- Economic Times
Chemkart India IPO: Check GMP, price band and other details
Mumbai's Chemkart India, a B2B food and health ingredient distributor, is launching its IPO today. The company aims to raise Rs 80.08 crore. The IPO includes a fresh issue and an offer for sale. The issue closes on July 9, with BSE SME listing expected on July 14. Proceeds will fund expansion and debt repayment. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Chemkart India, a Mumbai-based B2B distributor of food and health ingredients, will open its IPO today, aiming to raise Rs 80.08 crore through a mix of fresh issue and offer for sale. The three-day issue will close on July 9, with shares expected to list on the BSE SME platform on July IPO comprises a fresh issue of 26 lakh shares aggregating up to Rs 64.48 crore and an offer for sale (OFS) of 6.29 lakh shares worth Rs 15.60 price band is fixed at Rs 236–248 per share, with a lot size of 600 shares. Ahead of the issue opening, the GMP is Rs 0 in the unlisted Horizon Capital Advisors is the lead manager to the issue, with Bigshare Services as registrar. Alacrity Securities is the market in 2015, Chemkart operates in the health and food ingredients segment, supplying amino acids, herbal extracts, vitamins, proteins, and sports nutrition components to supplement company also offers in-house services like grinding, blending, and packaging at its 28,000 sq. ft. facility in Bhiwandi, enhancing its control over quality and IPO proceeds will fund capital expenditure through investment in its wholly owned subsidiary, Easy Raw Materials, repay existing borrowings, and meet general corporate of FY25, Chemkart reported a 55% jump in revenue to Rs 205.46 crore and a 67% rise in profit after tax at Rs 24.26 crore. Its return on equity stands at 59%, with a healthy EBITDA margin of 16.12%.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Time of India
an hour ago
- Time of India
The Xi Jinping question: Is China's 'leader for life' planning his exit? Or just delegation of powers?
Chinese President Xi Jinping, seen widely as a leader for life, is reportedly beginning to delegate authority to key institutions of the ruling Communist Party, raising speculation about a possible transition of power or retirement planning after over a decade at the helm. According to a report by state-run Xinhua news agency, the 24-member Political Bureau of the Communist Party of China (CPC) reviewed a new set of regulations during its meeting on June 30. The meeting, presided over by Xi, focused on standardising the responsibilities, establishment, and functioning of the CPC Central Committee's decision-making, deliberative, and coordinating institutions. Xinhua noted that these institutions are expected to enhance leadership and coordination on major national tasks. The announcement triggered talk among observers that Xi, in power since 2012, may be preparing for a shift in his role. A political analyst based in China, speaking to the South China Morning Post on condition of anonymity, said: 'The rules may be set up to regulate the bodies because it's a key time for power transition.' The Hong Kong-based publication carried the report on Sunday. However, other experts suggest the changes may simply reflect Xi's desire to step back from day-to-day governance while retaining overall control. Victor Shih, a specialist in Chinese elite politics and finance at the University of California San Diego, told the Post, 'It does seem that Xi might pay less attention to day-to-day details, which necessitates a policing mechanism to ensure that his policy priorities are still being carried out by lower-level officials. ' Adding to the speculation was Xi's absence from the BRICS summit in Rio de Janeiro, which began on Sunday. For the first time since assuming the presidency, Xi skipped the gathering of emerging economies. Chinese Premier Li Qiang is representing the country instead. The backdrop to this development includes mounting pressure on China's economy. The ongoing tariff war with the US, which has impacted exports worth USD 440 billion, combined with a slump in the housing market and the effects of the now-abandoned zero COVID policy, has weighed heavily on economic growth. Since becoming General Secretary of the CPC in 2012, Xi rapidly consolidated power across the party, the presidency, and the military. He led a massive anti-corruption campaign, resulting in punishment for over a million officials and the removal of several top generals. In 2016, he was declared the 'core leader' of the party, a status previously held only by founder Mao Zedong. In 2018, China's legislature scrapped the presidential term limit, enabling Xi to secure an unprecedented third five-year term as General Secretary in 2022, followed by a third presidential term in 2023. His predecessors had retired after two terms. Analysts believe that Xi's plans—whether to retain control or facilitate an eventual handover—may become clearer by the next CPC congress scheduled for 2027, when his current term ends.
